Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 50.30
+0.10 (0.20%)
At close: Sep 17, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 5.38 billion as of September 17, 2026.
Market Cap
5.38B
Enterprise Value
4.81B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
50.30
ChartMarket Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has increased from 4.62B to 5.38B, an increase of 16.44%. That is a compound annual growth rate of 20.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 5.39B | 29.34% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 37.60B |
| HanchorBio | 19.47B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.93B |
| Intelligene | 7.05B |
| Uwell Biopharma | 5.71B |
| Tripartite Therapeutics | 5.42B |
| BIONET Therapeutics | 2.44B |
| Pet Pharm Biotech | 2.25B |